| |
| |
|
| Insider
Information: |
Eastbourne Capital Management Llc/ca |
| Relationship: |
10% Owner |
| City: |
San Rafael |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
44,385,290 |
|
|
Indirect Shares
|
48,092,752 |
|
|
| Direct
Value |
$1,018,809,382 |
|
|
|
Indirect Value
|
$566,400,451 |
|
|
| Total
Shares |
92,478,042 |
|
|
| Total
Value |
$1,585,209,833 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cassava Sciences Inc |
SAVA |
10% Owner |
2009-09-29 |
3,230,204 |
2007-12-31 |
10,901,174 |
Premium* |
|
|
Mabvax Therapeutics Holdings Inc |
MBVX |
10% Owner |
2009-09-30 |
11,850,000 |
2010-05-10 |
1,532,709 |
Premium* |
|
|
Amylin Pharmaceuticals Inc |
AMLN |
10% Owner |
2009-09-17 |
13,346,120 |
2007-12-31 |
20,220,126 |
Premium* |
|
|
MGIC Investment Corp |
MTG |
10% Owner |
2009-09-16 |
10,299,755 |
2009-03-11 |
15,438,743 |
Premium* |
|
|
Sarepta Therapeutics Inc |
SRPT |
10% Owner |
2010-03-04 |
5,659,211 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MBVX |
Mabvax Therapeutics Holdi... |
10% Owner |
– – • |
2010-05-10 |
4 |
D |
$0.00 |
$0 |
I/I |
(10,317,291) |
1,532,709 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
10% Owner |
– – • |
2010-03-04 |
4 |
S |
$1.24 |
$5,077,361 |
D/D |
(4,094,646) |
5,659,211 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
10% Owner |
– – • |
2009-11-11 |
4 |
S |
$1.41 |
$473,092 |
D/D |
(333,950) |
13,890,188 |
0 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
10% Owner |
– – • |
2009-09-30 |
4 |
S |
$0.79 |
$37,572 |
D/D |
(47,385) |
11,850,000 |
0 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
10% Owner |
– – • |
2009-09-29 |
4 |
S |
$0.81 |
$116,379 |
D/D |
(143,068) |
11,897,385 |
0 |
- |
|
| SAVA |
Cassava Sciences Inc |
10% Owner |
– – • |
2009-09-29 |
4 |
S |
$4.98 |
$10,318 |
D/D |
(2,073) |
3,230,204 |
0 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
10% Owner |
– – • |
2009-09-28 |
4 |
S |
$0.84 |
$179,389 |
D/D |
(213,547) |
12,040,453 |
0 |
- |
|
| SAVA |
Cassava Sciences Inc |
10% Owner |
– – • |
2009-09-28 |
4 |
S |
$4.98 |
$7,746,226 |
D/D |
(1,556,842) |
3,232,277 |
0 |
- |
|
| SAVA |
Cassava Sciences Inc |
10% Owner |
– – • |
2009-09-25 |
4 |
S |
$4.98 |
$7,552,050 |
D/D |
(1,518,000) |
4,789,119 |
0 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
10% Owner |
– – • |
2009-09-22 |
4 |
S |
$0.86 |
$826,948 |
D/D |
(948,538) |
12,254,000 |
0 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
10% Owner |
– – • |
2009-09-21 |
4 |
S |
$0.99 |
$125,285 |
D/D |
(126,653) |
13,202,538 |
0 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
10% Owner |
– – • |
2009-09-17 |
4 |
S |
$1.19 |
$48,988 |
D/D |
(41,100) |
13,329,191 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
10% Owner |
– – • |
2009-09-17 |
4 |
S |
$13.89 |
$20,124,372 |
D/D |
(1,443,241) |
13,346,120 |
0 |
- |
|
| MTG |
MGIC Investment Corp |
10% Owner |
– – • |
2009-09-16 |
4 |
S |
$8.96 |
$41,278,295 |
D/D |
(4,600,245) |
10,299,755 |
0 |
- |
|
| MBVX |
Mabvax Therapeutics Holdi... |
10% Owner |
– – • |
2009-09-16 |
4 |
S |
$1.20 |
$125,159 |
D/D |
(104,709) |
13,370,291 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
10% Owner |
– – • |
2009-09-16 |
4 |
S |
$14.09 |
$34,088,489 |
D/D |
(2,410,639) |
14,789,361 |
0 |
- |
|
| MTG |
MGIC Investment Corp |
10% Owner |
– – • |
2009-09-15 |
4 |
S |
$8.72 |
$19,126,709 |
D/D |
(2,100,000) |
14,900,000 |
0 |
- |
|
| MTG |
MGIC Investment Corp |
10% Owner |
– – • |
2009-09-14 |
4 |
S |
$9.10 |
$13,719,925 |
D/D |
(1,500,000) |
17,000,000 |
0 |
- |
|
| SAVA |
Cassava Sciences Inc |
10% Owner |
– – • |
2009-08-07 |
4 |
S |
$3.96 |
$6,585,480 |
D/D |
(1,663,000) |
6,307,119 |
0 |
- |
|
| SAVA |
Cassava Sciences Inc |
10% Owner |
– – • |
2009-07-14 |
4 |
S |
$4.26 |
$192,440 |
D/D |
(45,000) |
7,970,119 |
0 |
- |
|
| SAVA |
Cassava Sciences Inc |
10% Owner |
– – • |
2009-07-13 |
4 |
S |
$4.17 |
$191,429 |
D/D |
(45,778) |
8,015,119 |
0 |
- |
|
| SAVA |
Cassava Sciences Inc |
10% Owner |
– – • |
2009-07-07 |
4 |
S |
$4.54 |
$1,686,436 |
D/D |
(368,000) |
8,060,897 |
0 |
- |
|
| SAVA |
Cassava Sciences Inc |
10% Owner |
– – • |
2009-06-15 |
4 |
S |
$5.00 |
$142,427 |
D/D |
(28,103) |
8,428,897 |
0 |
- |
|
| SAVA |
Cassava Sciences Inc |
10% Owner |
– – • |
2009-06-12 |
4 |
S |
$5.04 |
$947,392 |
D/D |
(185,780) |
8,457,000 |
0 |
- |
|
| SAVA |
Cassava Sciences Inc |
10% Owner |
– – • |
2009-06-11 |
4 |
S |
$5.00 |
$359,784 |
D/D |
(71,820) |
8,642,780 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
